HBV Clinical Trials

5 recruiting

Frequently Asked Questions

Common questions about HBV clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

Hepatocellular CarcinomaHIV InfectionsCirrhosis, Liver+6 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS20 enrolled1 locationNCT07429864
Recruiting

Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)

HIVHBVHCV+3 more
MagIA Diagnostics2,950 enrolled2 locationsNCT07170748
Recruiting
Not Applicable

Prospective Clinical Performance Evaluation of the In-Vitro Diagnostics Medical Device MaGIA IBC for the CombIned screENing of HIV, Hepatitis B and Hepatitis C

Combined Point of Care Diagnostic of HIV, HBV and HCV
MagIA Diagnostics252 enrolled2 locationsNCT06082336
Recruiting

Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease

Liver NeoplasmLiver FibrosisHBV Infection+1 more
Nanfang Hospital, Southern Medical University240 enrolled1 locationNCT07265544
Recruiting

Risk Assessment for HBV-Related Liver Cancer

HBV-related Liver Cirrhosis
Sun Yat-sen University6,000 enrolled1 locationNCT07160946
Recruiting

Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study

Hepatitis B, Chronic (CHB)Hepatitis BHepatitis B Virus (HBV)
First Affiliated Hospital Xi'an Jiaotong University1,500 enrolled2 locationsNCT07079150
Recruiting

New HBV Infection Biomarkers: Clinical Characterization and Impact on Management

Chronic Hepatitis B Virus (HBV) Infection
Assistance Publique - Hôpitaux de Paris900 enrolled1 locationNCT06906016
Recruiting

Non-Invasive Model for Fibrosis Regression in HBV Patients

Chronic Hepatitis B Virus (HBV) InfectionLiver Fibrosis
Beijing Friendship Hospital1,100 enrolled1 locationNCT06874127
Recruiting

Study on the Treatment of Hepatitis B Virus(HBV) Infected Individuals With Peginterferon α-2b Combined With NA.

HBV
Xiangya Hospital of Central South University400 enrolled4 locationsNCT06746701
Recruiting
Not Applicable

The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM)

HIVHBVSyphilis
Institut de Recherche pour le Developpement2,800 enrolled2 locationsNCT05951751
Recruiting

Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC)

Cirrhosis, LiverHCCHBV+2 more
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis60 enrolled1 locationNCT05781568